Daniel Einhorn, MD, on HbA1c Guidelines Are Not Law



Dr Daniel Einhorn talks about the "debate of 2018": ACP's new guidance on controlling HbA1c levels in adults with diabetes.

Daniel Einhorn, MD, is a Clinical Professor of Medicine at the University of California, San Diego; Medical Director of the Scripps Whittier Diabetes Institute; Associate Editor of the Journal of Diabetes; and President of Diabetes and Endocrine Associates in La Jolla, California.

For more content about diabetes, visit our Medical Resource Center.

To register for Consultant's Cardiometabolic Risk Summit, visit our website here.

American College of Physicians' Guidance Statement on HbA1c